Detalhe da pesquisa
1.
Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network.
Am J Hum Genet
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38688278
2.
Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores.
Genet Med
; 25(9): 100906, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246632
3.
Returning integrated genomic risk and clinical recommendations: The eMERGE study.
Genet Med
; 25(4): 100006, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621880
4.
Attitudes among Parents towards Return of Disease-Related Polygenic Risk Scores (PRS) for Their Children.
J Pers Med
; 12(12)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556166
5.
Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron disease.
PLoS One
; 17(9): e0274615, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107978
6.
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.
Front Oncol
; 12: 859846, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35865463